Britannia Life Sciences Inc. (CNSX:BLAB) entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited on April 7, 2022. Upon completion of the Additional ADSL Purchase, Britannia will own a 70% interest in ADSL, Britannia's largest operating subsidiary. Gowling WLG (UK) LLP and Bennett Jones LLP acted as legal advisor to Britannia Life Sciences Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 CAD | -8.33% |
|
-8.33% | -26.67% |
1st Jan change | Capi. | |
---|---|---|
-26.67% | 6.51M | |
+12.74% | 8.09B | |
+0.47% | 7.39B | |
-9.03% | 5.37B | |
-8.36% | 3.63B | |
-17.97% | 3.27B | |
-13.17% | 1.19B | |
-25.62% | 1.13B | |
+1.96% | 879M | |
-15.09% | 867M |
- Stock Market
- Equities
- BLAB Stock
- News Britannia Life Sciences Inc.
- Britannia Life Sciences Inc. entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited.